Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |